Objectives: Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor used in the treatment of HIV infections. It has been reported that NVP has a toxic effect on the liver, kidney and male reproductive system. This study was designed to assess the NVP toxic effects on these tissues (liver, kidney and testis) and its possible genotoxic and mutagenic effects. Methodology: Forty adult male albino rats were divided into 4 groups (10 rats each): (A) negative control group, (B) positive control group received 1ml/ day of corn oil, (C) NVP1 treated group received 3.6mg (loading dose) of the drug for 2 weeks and (D) NVP2 treated group received the loading dose of the drug for 2 weeks then 7.2 mg (maintenance dose) for 2 weeks more. Results: The results of present study revealed the followings: NVP did not alter the body weight gain or kidney weight, but it increased liver weight in (group C) and decreased testis weight in (group D). NVP caused a high significant increase of liver function tests (serum aspartate transferase, alanine transaminase, alkaline phosphatase and total bilirubin), a high significant decrease in hormonal levels of testes (testosterone, FSH and LH) and no significant difference on kidney function tests (urea and creatinine). Histopathological changes in liver and testis in NVP-treated groups were observed as compared to control groups. Comet assay showed that NVP caused a highly significant damage in blood cells in a dose dependent fashion. This result suggests for the first time that this drug might induce genotoxicity in the whole blood. Conclusion: oral exposure of adult albino rats to NVP at a human therapeutic dose daily for 4 weeks leads to toxic effects on liver and damaging effect on male reproductive system in addition to the genotoxicity.
INTRODUCTION
Nevirapine (NVP) is a first-generation of non nucleoside reverse transcriptase inhibitors (NNRTIs), cheap and widely available around the world. It has several advantageous characteristics and little adverse CNS events when compared with efavirenz (NNRTI), fewer drug interactions than protease inhibitors (PIs) and its bioavailability is not affected by food (Bieńczak et al., 2017; Cˇolic et al., 2015) .
Nevirapine is usually used as a part of the extremely active antiretroviral therapy (HAART) in resource-limited settings. Currently, it remains one in every of the foremost prescribed ARVDs in developing countries, to stop vertical transmission (mother-to-child) once utilized in combination therapy (Lockman et al.,
2007).
This antiretroviral therapy (ART) is ca pable of reducing the quantity of HIV and improving the functioning of the immune s ystem, but unfortunately, extended use will trigger many adverse effects such as rash, hypersensitivity syndrome, and hepatotoxi city (de Maat et al., 2007; Roca, 2009 ).
The most common adverse effects related to presently used ART regimens are anaemia, itching, skin rash, elevated triglycerides, peripheral neuropathy, thrombocytpenia, p ancreatitis and most dangerous is hepatotoxicity (Rather et al., 2013).
Hepatotoxicity associated with NVP was identified by 3-fold increase greater than the upper normal values of liver enzymes; serum ALT and/ or serum AST (Cabello et al., 2015).
Renal disease before start of HAART is quite common in HIV infected patients (Banda et al., 2010). However, long term exposure to HAART may also be associated with significant renal toxicity (Manosuthi et al., 2010). Renal dysfunction is mainly attributed to Tenofovir (NtRTIs) and PIs, but very few studies have been done to determine the contribution of other antiretroviral agents (Makori et al., 2015) .
The adverse effects of HAART on fertility especially in growing societies have become a significant cause for attention. As HIV is most prevalent among people of reproductive age, about onethird of who want to have kids, reproductive desires have emerged as clinically important in people living with HIV/AIDS (PLWHAs) (Kushnir & Lewis, 2011).
According to de Oliveira et al. (2014) , acute exposure of ordinary mice to NVP d id not trigger important degrees of genotox icity or mutagenicity (de Oliveira et al., 2014).
AIM OF THE WORK
The aim of this study is to assess the toxic effects of nevirapine (non-nucleoside reverse transcriptase inhibitor) on different tissues (liver, kidney and testis) and to study its genotoxic and mutagenic effects on male adult albino rats.
MATERIALS AND METHODS

I-Materials: A-Chemicals:
 Nevirapine (Viramune) as tablets (CAS number: 129618-40-2) was purchased by Boehringer Ingelheim (France).
 Corn oil as a liquid of purity ± 99% (CAS number 8001-30-7) was purchased from Sigma-Aldrish (ST Louis, Missouri, USA).
B-Animals:
This work was carried out on forty male adult albino rats weighing between 180gm and 200gm. All rats were allowed for one week of adaptation (taking food & water without any medications) in their new environment at Anatomy Department, Faculty of Medicine, Benha University.
The local Ethical Committee, Benha F aculty of Medicine, recognized this study.
C-Animal groups
At the beginning of the study, randomization was done and animals were categorized into four groups (10/ group):
Group (A) male negative control group (10 male rats): lifted without intervention to record the basic parameters, with free access to food and water for 4 weeks. Each rat received NVP orally, via appropriate sized metallic cannula dressed with plastic cover (oral gavage) that not exceeds the tip by 2-3 ml to prevent injury of the esophagus.
Group
Sample collection:
After the end of the experimental time for each group, rats were anaesthetized with ether inhalation, the abdominal cavity was opened, and blood samples were collected from heart and prepared for biochemical measurements and comet assay. The liver, kidney and testis were collected and putted in 10% formalin to do the histopathological study.
Methods (study parameters):
Body and relative organs weight, general health and gross behavior of the animals:
All animals were observed daily for general clinical and behavioral changes. The clinical response and behavior were monitored for 1 h after drug administration and periodically for 24 h. The behavior was assessed by observing the animals' social contact with littermates in the cage. The macroscopic appearance of animals was evaluated by checking the animals' fur for cutaneous reactions (de Oliveira et al., 2014).
Also, animals' body weights were measured on the first day before treatment, at two weeks and four weeks later at the end of intervention. Individual organ weight was measured using sensitive electronic balance, after scarification, the organs of each rat were weighed separately and the relative organ weight was calculated using the equation of (organ weight/ body weight x 100).
Biochemical study: Liver enzymes:
Spectrophotometrically, AST, ALT, alkaline phosphatase (ALP) and total bilirubin levels were measured using the commercial test of each with spinlab(Spinreact company), Spain.
Kidney enzymes:
Urea and creatinine levels were calculated spectrophotometrically using the commercial test of urea with spin lab (Spinreact company), Spain.
Hormones:
Using Enzyme Linked Fluorescent Assay, Testosterone, Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) levels were detected, using the commercial kits VIDAS for each (BIOMERIEUX Company, France) using VIDAS apparatus (BIOMERIEUX Company, France). Histopathological study:
After staining with Haematoxylin and Eosin (H&E), sections from liver, kidney, and testis were studied by light microscope. Comet assay:
Sample preparation
Dhawan et al. (2003) altered a traditi onal protocol for sample preparing and co met assay analysis. After sample slides prepration, the slides were dipped into lysis solution at 4 ° C for 1 day. Subsequently, the slides were placed at roo m temperature for 20 minutes in an electro phoresis buffer to generate single stranded DNA. Electrophoresis was then linked to a new, cold electrophoresis buffer at 300 mA and 19 V in a horizontal electrophoresis platfor m for 20 minutes. Then, neutralization of the gel is by rinsing the slides with suitable buffer (Tris pH 7.5) for 5 min three times for 5 min. / each. Before staining slides were dehydrated by immersing in absolute ethanol for 5min.The slides were stained for 10 minutes with 10% ethidiumbromide.
The slides were evaluated using the pr epared Leitz Orthoplanepi fluorescence mi croscope with a 515-560 nm excitation filter.100 randomly selected cells, respectively, were photographed and scannedin every irradiation dose. Analysis was done by image analysis using comet score software.The comet cell characters that we re chosen were tiny heads and big fanlike tails. The duration of DNA migration (tail lengt h) from the middle of the nucleus to the tail end was evaluated in (μm) for ea ch cell.The proportion of DNA in the tail was determined by evaluating the cells ' co mplete intensity (fluorescence), which was taken as 100%, and determining which pr oportion of that complete intensity corresp onded to the intensity measured in the tail only.The tail moment was calculated as: (t ail length X proportion of migrated DNA/1 00) expressed in arbitrary units (Końca et al., 2003).
Statistical analysis:
SPSS version 16 soft ware (SpssInc, Chicago, ILL Company) was used to analyse and tabulate the gathered data.Data was displayed as mean deviation and range ± standard. They have been scre ened for normality with the Shapiro-Wilks test assuming normality t P>0.05, ANOVA test was used to analyze difference between groups regarding normally distributed variables, while non parametric ones were analyzed using Kruskal Wallis (KW) test. Significant ANOVA or KruskalWallis tests were followed by post hoc multiple comparisons using Bonferroni tests to detect the significant pairs. According to Greenberg et al. (1996) and Khothari (2004), the accepted standa rd of meaning in this job was indicated at 0 .05 (P value > 0.05 was considered insigni ficant, P < 0.05 was regarded important an d P<0.001 was regarded extremely importa nt).
RESULTS
I-Observations during the study: A) Behavioral changes:
There were some behavioral changes that had been observed in nevirapine (NVP1) and (NVP2) treated groups. These changes were isolated from others and lack of movement, which were transient and occurred approximately 1 week after beginning of the study. Dermal changes:
Skin rashes were noticed in rats of both treated groups. These rashes gradually increased and lasted to the end of the study.
II-Weight of the body and organs:
No statistical significant (p> 0.05) difference are showed in all studied groups at the start of the study, at the end of the 2 nd week and 4 th week of drug administration regarding body weights (Table 1) . The only statistical change a highly significant increase in mean values of relative liver weight in NVP1treated group as compared to the control groups and NVP2treated group. There is no statistically significant difference between NVP2treated group and the control groups. Also, there is a highly significant decrease in mean values of relative testis weight in NVP2treated group as compared to the control groups and NVP1treated group. But, there is a non statistical significant Egypt J. Forensic Sci. Appli. Toxicol.
Vol 20 (1), Mar 2020 between the four groups regarding mean values of relative kidney weight (Table 2) .
III-Biochemical study:
A highly significant increase is observed in mean values of AST, ALT, ALP and total bilirubin levels in NVP1and NVP2treated groups as compared to the control groups. Also, there is a highly significant between NVP1and NVP2treated groups regarding these parameters (Table 3) .
No statistical significant (p> 0.05) difference are showed in all studied groups regarding mean values of urea level and creatinine level (Table 4) .
Regarding the hormonal assessment, there is a highly significant decrease in mean values ofFSH,LH andtestosterone levels in NVP1and NVP2treated groups as compared to the control groups. There is no statistical significant between the treated group according the same parameters (Table 5 ).
IV-Histopathological study:
Histopathological examination of the liver of the NVP1 treated group showed changes in liver histopathology as central vein congestion, fatty degenerations with singent ring appearance, hydropic degeneration. These changes aggravated in NVP2treated group with appearance of marked necrosis and major distortion of architecture. There were no histopathological changes on examination of NVP1and NVP2treated group kidneys. Testicular tissue examination, however, di sclosed degeneration of seminiferous tubul es (ST), spermatocyte necrosis and defoliat ion of many spermatocytes into ST lumen, which worsened in NVP2 compared to NV P1 ( fig. 1) .
V-Single cell electrophoresis (comet assay):
Tail lengthand moment mean values were significantly higher among the treated group than the controls. And there is no statistical significant between both treated groups (Table 6 ).
In both treated groups, the comet as say showed a substantial rise in tail length relative to controls.NVP2treated group had increasing in tail length as compared to tail length of NVP1treated group which was indicated more severe DNA damage as shown in (fig 2) . Egypt J. Forensic Sci. Appli. Toxicol.
Vol 20 (1), Mar 2020 
DISCUSSION
Nevirapine is the first line drug for HIV infection from the category of NNRTI (Mohamed et al., 2019) . Bioavailability of NVP in rats is more than 90% and it is absorbed by the small intestine and colon as that observed in humans, which makes the rat a perfect animal model for performing studies on the absorption of NVP (Usach & Peris,  2011) .
The present work experimentally was studied on male adult albino rats, aimed to assess the toxic effects of NVP on (liver, kidney & testis) and to investigate the genotoxic effect of the drug.
Results of this study showed behavioral changes that had been observed in NVP1and NVP2 treated groups. These changes were fatigue and lack of movement of some rats, which were transient and occurred approximately 1 week after beginning the study.
By comparison, de Oliveira et al. (20 14)'s research showed that the administrati on of NVP did not result in any modificati ons in the overall conduct (such as spasms, muscle tremors, salivation or sedation) on the rats being handled. This contrast might During the current study dermal changes were noticed.These changes were skin rashes which appeared from the 7 th day, gradually increased and persistent till the end of the study among rats of both treated groups.
These results are in agreement with Hall and Macgregor (2007) who suggested that patients administrated NVP produced skin rash would have higher blood levels of a major metabolite of nevirapine 12-hydroxynevirapine (12-OHNVP) (Riska et al., 1999) . That explained by Shenton et al. (2005) who stated that immune-mediated reaction to the metabolites of NVP was found, Pretreatment with immunosuppressants (cyclo sporine and tacrolimus) banned rash and e ven resulted in rash resolution during NVP therapy. The present study demonstrated a non significant (P > 0.05) difference between all studied groups regarding bodyweights before, at the end of 2 nd week and at the end of the study (4 th week).
In agreement with these results, Elias and Bonsome (2017) The rats were observed no failure to eat or drink during the period of the experiment and that explains the cause of no weight loss.
This research showed a very important rise in relative liver weight mean values in the treated NVP1 group compared to the o ther groups (control groups and treated NV P2 group).
These findings were in harmony with Adaramoye et al. (2012) who reported tha t NVP weight / day administration in rats i nduced a substantial rise (p<0.05) in relati ve liver weight. 27 On the other hand, Elias and Bonsom e (2017) noted that 14day therapy with dos es (4, 8, 16, 32) mg / kg / day of NVP had no important (p>0.05) impacts on relative l iver weights compared to control.
Increase relative liver weight of NVP1treated rats might be due to the hydropic and fatty degenerations (Hall et  al., 2012) . These were observed by histopathological examination in the current study.
The current study showed a non statistical significant difference between the four groups regarding relative kidney weight. The average relative kidney weights of -ve control, +ve control, NVP1 and NVP2 treated groups were 1.48, 1.39, 1.49 and 1.44 gm respectively. (2017) (2017 ) study and the current study might be due to the duration which it were 8 weeks in their study and 4 weeks in the present study.
Elias and Bonsome
The present study showed a highly significant decrease in the mean values of relative testis weight in NVP 2 treated group as compared to the control groups as well as to NVP 1 treated group. There was also no statistically significant d istinction between the group being handled Egypt J. Forensic Sci. Appli. Toxicol.
Vol 20 (1), Mar 2020 with NVP1 and the control groups. This observation was correlated with the totally damaged testis which seen in the histopathological examination. There was a harmony between these results and those of Ajayi et al. (2016) who reported that administration of NVP decreased the relative testis weight in treated rats. They explained that the decrease in relative testis weight in their study might be an indication of change in state of the body androgen (Biswas et al.,  2001) .
In contrast, Adaramoye et al. (2013) reported that administration of NVP did not significantly (p > 0.05) alter the relative testis weight.
A highly significant increase in mean values of serum AST, ALT, ALP and total bilirubin levels were showed in NVP1and NVP2 treated groups as compared to the control groups. Also, there is a highly significant increase in NVP1compared to NVP2 treated groups.
Partially agreed with the present result s by Olapido et al. (2016) . They discovered that NVP administration resulted in a substantial rise in mean valuesof AST and ALT relative to control but, compared to control, a reduction in mean values of A LP mean value.Umar et al. (2008) researc h findings alsofound that NVP administrati on resulted in important rises (p<0.05) in AST and ALT operations.But, total bilirubin was almost similar to that of the controls in their study.
In accordance with the current work, it has been found that management with human therapeutic dose of NVP caused liver injury through out hours after the first dose and thispersist up to 7 to 14 days.
There was no proof of subclinical hep atic injury on days 14 and 21, however, wh ich meant that the body overcame the path ological process of subclinical hepatic inju ry caused by NVP over time (Bekker et  al., 2012) .
Study by Wen et al. (2009) revealed t hat CYP3A4 transformed NVP metabolica lly into quinone methidine, a toxic reactive metabolite, and, to a smaller extent, CYP2 D6, CYP2C19, and CYP2A6, this metabol ite may prevent its development.
This may explain the hepatic injury im provement after 14 and 21 days of therapy in part (Bekker et al., 2012) .
Elias and Bonsome (2017) found that treatment with doses (4, 8, 16, 32) mg/kg/day of NVP for 14 days observed dose-dependent increases in serum and liver levels of ALT, AST, and ALP in NVP treated juvenile albino rats.
As a consequence of cellular leakage a nd loss of functional integrity of the liver c ell membrane, the observed rises in serum concentrations of AST, ALT, and ALP ma y be due to the release of these enzymes in to the blood.
In addition, the elevation of serum tota l bilirubin may be attributed to overproduc tion, impaired uptake, conjugation or excre tion of unconjugated or conjugated bilirubi n from hepatocytes to bile ducts caused by NVP (Thapa and Walia, 2007) .
Partially in agreement with the present results, Adaramoye et al. (2012) noted th at NVP administration at 18 mg / kg body weight / day for 4 weeks did not result in a ny important (p > 0.05) variations in the A LT and AST and ALP serum concentration s of rats handled with NVP relative to cont rols.But, NVP considerably enhanced seru m concentrations of ALT, AST, and compl ete bilirubin concentrations in rats at 36 m g / kg body weight / day for 4 weeks of int oxication (p < 0.05).
The current study reported no statistically significant difference between the four groups regarding mean values of urea and creatinine levels. Mean values of urea of -ve control, +ve control, NVP1 and NVP2 treated groups were 26.8, 27.6, 33.2 and 28.6 mg/dl respectively, and for creatinine levels were 0.48, 0.50, 0.62 and 0.72 mg/dl respectively.
These findings were in a harmony with 2008) . Therefore, NVP did not interfere wi th the animals ' renal functions at the two d oses administered. These results were supported by the histopathological changes of the slides taken from kidneys of the animals.
The present work showed a highly significant decrease in mean values of FSH, LH and testosterone levels in NVP1and
NVP2treated groups as compared to the control groups. There is no statistical significant difference between the control groups; Also, there is no statistical significant difference between the treated groups.
The current findings were also in a harmony with those of Awodele et al. (2018) who found significant (p < 0.05) reductions in the blood levels of the hormones measured (LH, FSH and testosterone) in the treated group with NVP when compared to the control indicating a significant reduction in reproductive competency and point to a possible and potentially damaging adverse effect of NVP.
Decreased serum FSH, LH and testosterone levels indicated that male reproductive toxicity induced by NVP as well as a decreased function of Sertoli cell, in addition to the direct cytotoxic effects on germ cells.
The histopathological changes of the liver specimens of the loading dose treated group (NVP1) were including central vein congestion, fatty degenerations with singet ring appearance, hydropic degeneration.
Also, treated maintenance dose group (NVP2) showed changes in liver histopathology as severe portal and central venous congestion and major distortion of architecture with marked necrosis.
These findings are consistent with Eli as and Bonsome (2017 With respect to histopathological mod ifications in the current research, microsco pic examination of male rat testicular samp les disclosed seminiferous tubules (ST), sp ermatocyte necrosis, and defoliation of ma ny spermatocytes intoST lumen.The changes were mild in loading dose treated group and more extensive in maintenance dose treated group.
The were also observed in the test interstititial spaces.
The cause of these modifications may be due to nevirapine crossing the blood tes tis barrier by entering the junctional cell co mplexes, affecting the tubular microenviro nment and causing death of germ cells (Meistrich et al., 1982) The current study showed that a highlysignificant increase in mean values of comet%, tail length, DNA % of tail and tail moment in NVP1and NVP 2 treated groups as compared to the control groups. There is no statistical significant between the control groups and no statistical significant between both treated groups.
Although de Oliveira et al. (2014) ob served that the group treated with acute N VP (3.3 mg/kg single dose in 24 hours) an d the subchronic treated group (3.3 mg / kg once daily for 36 consecutive days) did no t show significant levels of genotoxicity or mutagenicity by using comet assay compa red to the control group.
This controversy might be due to difference at the used dosage between the two studies. So, the genotoxic effect of NVP needs induction of more studies to ensure it on human.
CONCLUSION
In conclusion, this studyobserved that oral NVP administration at human loading and maintenance doses in rats (3.6 mg/ 200g, 7.2 mg/ 200g) respectively produced biochemical changes on liver functions of male adult albino rats. These biochemical changes were associated with histopathological effects on their livers. Also, the same doses of NVP produced hormonal disruption effects in male rats. These disrupted effects were associated with histopathological damaging effects on testes. But, NVP did not disrupt renal histo-architecture or biochemical functioning of kidney. On the other hand, this current study demonstrated that human theraputic dose of NVP induced genotoxic effects on whole blood cells of albino rats.
RECOMMENDATIONS
From the results of the present study, it can be recommended that:
1. Nevirapine should be used with cau tion and close tracking of liver enzymes as this can be critical in stopping incidents th at threaten life.
2. Further clinical studies on the HIV infected individuals to assess the extent of genotoxic effects induced by the drug on blood and various organs of the body.
3. No countries should be using NVPbased regimens. 
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